Growing Physician Adoption of AI Points to Expanding Market for Clinical Tools

According to a recent LinkedIn post from Carta Healthcare, survey data from the American Medical Association suggests accelerating adoption of AI tools among physicians. The shared figures indicate that four out of five physicians reportedly use AI in their practice, averaging 2.3 AI-supported tasks versus roughly half that level in 2023.

The post highlights that clinical documentation and research summaries are the most common use cases, with usage in these areas described as rising 26 percentage points to 39%. Physicians in the survey reportedly see AI as most helpful for work efficiency, diagnostic ability, and reducing cognitive overload, and a majority believe AI gives them an advantage in patient care.

At the same time, the content underscores persistent concerns, particularly around patient privacy, where more physicians reportedly expect harm than benefit. Many also express worry about potential skill loss from AI reliance and want meaningful input on how AI is implemented in their workflows, reinforcing the view that clinician oversight remains critical.

For investors, this LinkedIn post points to an expanding addressable market for healthcare AI vendors like Carta Healthcare, especially in documentation, research support, and clinical decision-augmentation tools. Rising physician acceptance could support demand for workflow-integrated solutions, potentially strengthening adoption and pricing power for platforms that align with clinician needs.

However, the emphasis on privacy risks and skill degradation concerns suggests regulatory scrutiny, data-governance requirements, and human-in-the-loop design will remain central to product strategy and sales cycles. Companies that can demonstrate strong compliance, transparent model governance, and clinician-centric design may be better positioned competitively and may see lower implementation friction.

The post’s reference to physicians’ desire for a say in AI adoption implies that successful vendors will need robust change-management, training, and co-design approaches with medical staff. For Carta Healthcare, this environment could favor offerings that integrate tightly into existing clinical workflows and electronic medical records, potentially supporting deeper customer stickiness and longer-term contracts.

More broadly, the trends cited in the post align with a structural shift toward AI-enabled healthcare operations, which could support sector-wide spending on data infrastructure and analytics. If the adoption trajectory described by the AMA survey continues, investors may see a sustained growth runway for specialized clinical AI firms, while also needing to monitor policy developments around privacy and professional standards.